End-stage renal disease in Tabuk Area, Saudi Arabia : an epidemiological study

• Published in: Saudi journal of kidney diseases and transplantation Vol. 25; no. 1; pp. 192 - 195
• Main Authors: al-Minshawi, Usamah, al-Basyuni, Iman, Ghabrah, Tawfiq Muhammad Ali
• Format: Journal Article
• Language: English
• Published: Riyadh, Saudi Arabia Saudi Center for Organ Transplantation 2014; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd; Wolters Kluwer Medknow Publications
• Subjects: Adult; Care and treatment; Chronic kidney failure; Demographic aspects; Diseases; Egypt - epidemiology; Etiology; Female; Humans; Kidney Failure, Chronic - diagnosis; Kidney Failure, Chronic - epidemiology; Kidney Failure, Chronic - therapy; Kidneys; Male; Middle Aged; Prevalence; Prevalence studies (Epidemiology); Renal Replacement Therapy; Risk Factors; Rural Health; Saudi Arabia - epidemiology; United States - epidemiology; Urban Health; الأمراض; الفشل الكلوي; الكلى; المرضى; علم الأمراض; علم الأوبئة; مسببات الأمراض; Saudi Arabia; United States; Egypt; United Kingdom
• ISSN: 1319-2442; 2320-3838
• DOI: 10.4103/1319-2442.124574

The purpose of this study was to determine the prevalence, etiology and risk factors of treated end-stage renal disease (ESRD) in the region of Tabuk, Saudi Arabia. We studied 460 renal replacement therapy patients through a review of medical records and patient interviews and obtained patient demographics, family history, risk factors for ESRD, environmental exposure to toxins, work conditions, social history and causes of death. The estimated prevalence of treated ESRD was 460 per million populations (PMP); 350 (76%) were treated by hemodialysis, 30 (7%) by peritoneal dialysis and 80 (17%) by kidney transplantation. The mean age was 48 ± 17 years, body mass index was 25 ± 2 kg/m2 and the male vs. female ratio was 64% vs. 36%. Most patients (55%) were living in rural areas. Etiology of the ESRD was unknown in 33%, hypertension in 24%, chronic glomerulonephritis in 8%, obstructive uropathy in 3.5%, analgesic nephropathy in 5%, Bilhaziasis in 0.5%, chronic pyelonephritis in 2% and diabetic nephropathy in 18%. Other causes such as gouty nephropathy, collagen diseases, toxemia of pregnancy and lupus nephritis constituted 6% of the cases. We conclude that the epidemiology of the treated ESRD in Tabuk area is similar to that in Egypt, but very different from that in the United States.